This is simply due to the fact that regardless of all the new pricing weapons retailers can deploy, and more potentially looming, weak consumer demand will continue to forcepricesdown.
They argue that Washington bureaucrats could force drug pricesdown even further, as occurs in the drug benefit for military veterans run by the federal Veterans Administration (VA).